Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Israeli artificial assisted reproductive sperm company seeks to establish a Chinese subsidiary.
| Project region | Israel |
|---|---|
| Industry | Biomedicine |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | real-time clinical quantitative phase microscope - 8 patents - seed round financing completed |
|---|---|
| Project description |
The Israeli company has the exclusive technology of a real-time clinical quantitative phase microscope. Its products are portable and easy-to-use devices, which can try in real time, stain the same but image pollution-free, and also evaluate DNA fragments. The company has obtained 8 patents for its core technology. The company's unique system uses a desktop workstation and disposable ink cartridge, which can be embedded into the clinical laboratory workflow to select sperm cells according to unified standards. In March 2019, the company completed the seed round financing (and A-round financing commitment). It seeks to set up a Chinese subsidiary to carry out clinical trials and obtain product certification for financing purposes. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us